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SUMMARY
Introduction: Prognostic factors following stroke remain to be established. The aim of this study was to deter-
mine early prognostic factors related with a 30-day mortality in first episode ischemic stroke patients.
Materials and methods: The study group comprised 329 consecutive patients, aged between 33 and 99 years
(mean age–SD 69–12.6) admitted within 24 hours following their first supratentorial ischemic stroke, con-
firmed either by computer tomography (CT) and/or autopsy. The following data were assessed within 24 hours
of hospitalization: gender, age, history of diabetes mellitus, history of ischemic heart disease, obesity, the neuro-
logical deficit at entry and after one day, level of consciousness at entry and after one day, electrocardiographic
dysrhythmia at entry, blood pressure at entry and body temperature on the first day following stroke. We also
assessed particular serum biochemical and hematological markers including: hematocrit, fibrinogen concentra-
tion, platelet count, white blood cell (WBC) count, gamma globulin level, glucose level, cholesterol level, the
erythrocyte sedimentation rate (ESR), and creatinine kinase (CK) level. The end-point for assessment was early
death (within 30 days). Statistical analysis consisted of univariate analysis and multiple regression.
Results: Univariate analysis demonstrated that an older age, increased neurological deficit at entry and on the
next day, decreased consciousness at entry and on the next day, electrocardiographic dysrhythmia, increased
body temperature and glucose level, decreased cholesterol level and increased CK level were significantly associ-
ated with death after 30 days (p£0.05). During multivariate analysis, only a severe neurological deficit
(Scandinavian Stroke Scale £15 points) both at entry and on the next day (OR=8.3; 95% CI: 2.83—24.35),
decreased consciousness within the first 24 hours of hospitalization (OR=19.2; 95% CI: 2.84—127.77) and
electrocardiographic dysrhythmia (OR=5.2; 95% CI: 2.37—13.77) were associated with death after 30 days.
Conclusion: A severe neurological deficit lasting 24 hours, decreased consciousness within 24 hours of hospital-
ization and electrocardiographic dysrhythmia are the most important indicators of 30-day mortality in patients
with first-time ischemic stroke.
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INTRODUCTION
Despite the decreased mortality rate observed in
the past two decades, stroke remains the major
cause of death and residual disability in highly
developed countries [1]. During the past few years,
great efforts have been made to determine factors
influencing the adverse outcome during the acute
phase of stroke. Early recognition of possible pre-
dictors seems essential for optimizing therapeutical
procedures, especially those, which are cost- and
time-consuming. This is extremely important in
countries such as Poland, where financial and
technical resources are limited. New treatment
methods such as thrombolytic therapy, require
clearly defined indications that need to be deter-
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mined within the first few hours following stroke
due to a narrow therapeutical window [2].
Factors that predict an adverse outcome or an
increased mortality include: increased age [3—7],
severe neurological deficit on admission [3,8—11],
decreased consciousness on admission [12—14],
presence of diabetes mellitus [15—18], atrial fibrilla-
tion [19—21], fever [22,23] and incontinence
[21,24]. Other studies have demonstrated the possi-
ble predictive role of impaired proprioception [25],
hemianopia [6,26] and a history of congestive heart
failure [13]. We also evaluated the significance of
normal (routine) laboratory tests as predictors of a
negative outcome or increased mortality. These
results suggest that an elevated ESR [4,27],
increased hematocrit, leukocytosis [27], hyper-
glycemia [4,28] and ECG or EEG abnormalities [14],
can be considered as potential prognostic factors.
Other predictive factors include a correlation
between the neuron-specific enolase/carnosinase
ratio and a worse 90-day outcome [29]. Another
group [30] suggested S-100 protein and neuron-spe-
cific enolase serum levels as predictors of a worse
outcome, while yet another demonstrated a correla-
tion between the abnormally low protein C level
and increased mortality after six months [31]. One
study suggested an association between poor stroke
outcome and lower cholesterol concentration [32].
Several studies that examined early CT findings
during acute stroke concluded that the presence of
a hyperdense middle cerebral artery sign [33—36]
and infarct size [14,37] are both correlated with a
negative outcome. One group demonstrated an
elevated positive predictive value of infarct volume
measured by means of the SPECT technique,
which predicted daily living activity impairment
one year following cerebral ischemia [38]. Finally
another group described the predictive role of the
ultrasound examination in patients with carotid
stroke [39].
There has been no general consensus as to
whether a battery of scales and dependent vari-
ables, or rather just one simple test, should be used
in predicting the outcome of stroke (acute phase).
Previous study results are inconsistent, mainly
because of observation period differences, varying
definitions of the term ÔoutcomeÕ and different
dependent variables. Additionally, some studies
concerned different sets of demographic data and
different clinical signs and symptoms.
Stroke mortality in Poland, considered to be a
Central European country, is still very high in com-
parison to Western European countries [40] (the
28-day mortality rate) [41]. Thus, we decided to
investigate the predictors of early mortality in first
episode ischemic stroke patients.
MATERIALS AND METHODS
Our study group comprised 329 ischemic stroke
patients, admitted to the Stroke Unit, Department of
Neurology, within 48 hours following stroke. Cerebral
ischemia was determined clinically and confirmed by
computer tomography (CT) and/or autopsy. A med-
ical history was collected in order to establish whether
there had been a previous stroke, were there any
stroke risk factors including hypertension, diabetes
mellitus, ischemic heart disease, or congestive heart
failure. These risk factors were grouped into classes:
patients with diabetes mellitus scored 1, and without-
scored 0. We estimated the stroke severity according
to the Scandinavian Stroke Scale (SSS) [20], both on
the day of admission (Day 0) and on Day 1. Patients
that scored £15 points on the SSS were considered to
have a Ôsevere deficitÕ while those with >15 points
were considered to have a Ôslight deficitÕ.
The level of consciousness both on admission and
the following day were graded on a subscale of the
SSS, which comprised Ôcoma, stupor, somnolence,
and normal alertnessÕ. During uni- and multi-variate
analyses patients with normal alertness were graded
as Ô0Õ, and patients with consciousness disturbances
were graded as Ô1Õ. On admission we performed
blood pressure measurements and an ECG. We
determined whether the patient presented with
atrial fibrillation or other cardiac dysrhythmia.
The following routine biochemical and hematologi-
cal parameters were collected after 12 hours of
fasting: hematocrit, WBC count, platelet count, fib-
rinogen concentration, gamma globulin level, glu-
cose level, total cholesterol level, ESR and CK activ-
ity. When identifying independent predictors of a
negative outcome, baseline biochemical and
hematological values, were graded as Ô0Õ (laborato-
ry normal values) and Ô1Õ (above normal laboratory
values). Table 1 presents normal laboratory values.
We evaluated the hematocrit, WBC and platelet
counts by means of the photometric method (Vega,
Roche), the fibrinogen concentration by means of
the coagulometric method (Beringher), the gamma
globulin level and CK activity by means of the enzy-
matic method (Hitachi), and the ESR by means of
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Parameter Survivors
n n% %
patients
Deceased
Patients
Men
Women
Age (years) [mean–SD]
Diabetes mellitus
Ischemic heart disease
Obesity
Hypertension
Severe neurological deficit on Day 0
Severe neurological deficit on Day 1
Decreased consciousness on Day 0
Decreased consciousness on Day 1
ECG evidence of dysrhythmia
Incontinence
Blood pressure on admission (mean–SD) 
Maximal body temperature during the first 24 hours of hospitalization
273
142
131
74
148
80
198
48
42
67
48
97
63
69.2–12.7* 74.3–11.3*
140.1–24.1
37.4–0.6ÛÛÛ
143.2–27.6
38.0–0.8ÛÛÛ
82.8
52
48
27.1
54.2**
29.3
72.5
17.6***
15.4#
24.8##
17.6###
35.7Û
23.5ÛÛ
56
27
29
15
41
15
37
37
40
34
38
39
36
17.2
48.2
51.8
26.8
73.2**
26.8
66.1
66.1***
71.4#
61.4##
68###
70.4Û
64.3ÛÛ
Table 2. Demographic data, vascular risk factors and baseline clinical data of patients who survived or died within 30 days following stroke onset.
* p£0.05 (StudentÕs t-test); ** c2=6.86, p=0.0088; *** c2=0.95, p=0.0001; # c2=0.75, p=0.00001; ## c2=28.58, p=0.0001; ### c2=60.83, p=0.00001;
Û c2=22.30, p=0.0001; ÛÛ c2=37.51, p=0.00001; ÛÛÛ p£0.05 (StudentÕs t-test)
the Westergren method. The serum glucose level
was measured by means of the photometric method
and total cholesterol was assayed by means of the
enzymatic method (CHOD-PAP), using commercial-
ly available kits (RA-1000, Boeringer-Mannheim).
Patients were followed up for 30 days following stroke.
We recorded mortalities and differentiated the cause
of death, according to the Oxfordshire Scale [42]. 
Statistical analysis 
Univariate analysis with the chi-squared test and
the StudentÕs t-test were used when needed. The
SSS score was reported as a median value
(25th—75th percentiles). The Mann-Whitney U
test was used for neurological deficit comparison
in SSS score patients who died and those who
survived. Significant variables during univariate
analysis were subject to multivariate regression in
order to identify data independently affecting the
30-day mortality.
RESULTS
Table 2 demonstrated the overall comparison of
demographic data, vascular risk factors and base-
line clinical data of patients who survived and died
within 30 days following stroke onset.
The overall patient age (329 patients) amounted to
70.0–12.6 years. Time of admission following
stroke onset is presented in table 3.
The median SSS score value on Day 0 in deceased
patients amounted to 7 (2—21) and those that sur-
vived 34 (24—41) (p£0.05). On Day 1 they scored
5 (0—16) vs. 34 (24—42) (p£0.05).
Out of 56 (17.2%) patients who died within 30
days following stroke, nine (16.1%) died due to
brain edema, 31 (55.4%) due to cardiac complica-
tions and 16 (28.7%) due to other medical compli-
cations.
Parameter Normal range Unit
Hematocrit
Fibrinogen
Platelet count
White blood cell count
Gamma globulin level
Cholesterol level
Erythrocyte sedimentation rate
Creatinine kinase activity
33 - 44 (women)
38 - 49 (men)
1.8 - 3.5
130000 - 350000
4000 - 10000
8 - 17
< 5.2
< 5
< 190
%
g / L
1/mm3
1/mm3
g / L
mmol / l
mm / h
U / L
Table 1. Normal laboratory  hematological and biochemical parameter
values assessed in the study.
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Table 4 presents various levels of decreased con-
sciousness observed on Day 0 and on Day 1.
Patients that died presented with a higher mean max-
imal body temperature on Day 1 and more patients
who died demonstrated a maximal body tem-pera-
ture ³37.5¡C (OR=3.02; 95% CI=1.56—5.81).
Atrial fibrillation was noted in 38.9% of patients
who died and in 20% of survivors. This was the
most frequent type of dysrhythmia.
Table 5 presents hematological and biochemical
data of survivors and deceased patients within 30
days following stroke.
Patients who died within 30 days following stroke
onset presented with an increased glucose level
(³6.4 mmol/l) (OR=2.75; 95% CI=1.47—5.14), CK
activity (>100 IU) (OR=2.65; 95% CI=1.37—5.11)
and lower cholesterol level (<5.2 mmol/l)
(OR=0.44; 95% CI=0.23—0.85).
Independent predictors of death within 30 days
following stroke, were based on baseline clinical
and biochemical data and identified by means of
regression analysis. These predictors comprised a
severe neurological deficit (Scandinavian
Neurological Score £15 points), both on Day 0 and
on Day 1 (OR=8.3; 95% CI: 2.83—24.35),
decreased consciousness on Day 0 or Day 1
(OR=19.2; 95% CI: 2.84—127.77) and electrocar-
diographic dysrhythmia on Day 0 (OR=5.2; 95%
CI: 2.37—13.77).
DISCUSSION
Knowledge of early predictors can influence the
assessment of the benefit/risk ratio in treating
patients with a poor prognosis, by identifying those
patients and encouraging physicians to apply a
more aggressive method of treatment. Early diag-
nosis enables an appropriate selection of patients
who can benefit from advanced methods of thera-
py. It seems especially important in countries such
as Poland, where access to advanced diagnostic
and therapeutical methods remains technically and
financially limited. Knowledge of early predictors
also allows for the qualification and stratification of
patients to be included in drug trials.
Current retrospective study results are consistent
with previous studies using multivariate analysis.
This study demonstrated that basic clinical data
such as a neurological deficit, decreased conscious-
ness and dysrhythmia are the most useful predictors
of mortality during the acute phase of stroke.
It seems almost impossible to establish the predic-
tive value of many parameters. This is due to
observation period differences, different study end-
points, clinical symptom rating scales, inclusion cri-
teria and non-comparable methods of statistical
analysis. Most previous results have been deter-
mined by means of univariate analysis. Some
results are difficult to use during everyday practice.
Table 5. Hematological and biochemical data in patients who survived
or died within 30 days following stroke onset.
Time
n
Patients
%
0 - 6  hours
6 -12 hours
12-24 hours
24 - 48 hours
186
70
55
18
56.5
21.3
16.7
5.5
Table 3. Time of admission following stroke onset
Survivors
n=273
Patients
Deceased
n=56
Hematocrit (%)
Fibrinogen (g/l)
Platelet count
White blood cell count
Gamma globulin level (g/l)
Glucose level (mmol/l)
Cholesterol level (mmol/l)
Erythrocyte sedimentation
rate on Day 0
Erythrocyte sedimentation
rate on Day 1
Creatinine kinase activity (IU)
42.4–5.0
2.9–0.9
229193–75279
9 434–5 250
21.4–5.5
6.7–2.4
5.5–1.3*
23.7–21.5
46.2–33.5
47 (28-105)**
42.8–7.1
2.7–0.8
237525–70122
10 534–4 322
22.4–6.7
4.9–2.1
4.9–1.3*
22.5–22.7
42.3–31.6
89 (42-231)**
Level of 
decreased
consciousness
Time
patients
Survivors Deceased
n % n %
Somnolence
Stupor
Coma
Day 0
Day 1
Day 0
Day 1
Day 0
Day 1
39
22
17
17
11
9
14.5
8.2
6.3
6.4
4.1
3.4
11
10
9
9
14
15
22
20
18
18
25
30
Table 4. Different levels of decreased consciousness in study patients.
* p£0.05 (Students t-test); ** p£0.05 (Mann-Whitney U test)
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They often include sophisticated biochemical [30]
or neuroimaging [38] methods, which are not easi-
ly available in central european countries (in
Poland and developing countries).
Multivariate analysis ensures more reliable conclu-
sions concerning patient outcome and therefore, is
often used in current studies. Most investigations
concerning 30-day mortality predictors deferred
consistent results. One group demonstrated that
higher ESR, WBC count and hematocrit values
were independent 30-day mortality rate predictors
[27]. Another group demonstrated that the persis-
tence of consciousness disturbances following 48
to 72 hours was the most important predictor and
that a history of congestive heart failure lead
towards a poor prognosis in fully conscious patients
[13]. One study tried to determine prognostic fac-
tors during the first six hours following stroke in the
carotid artery area and only noted the severity of
the neurological deficit as an independent predic-
tor of an increased mortality [8]. ECG and EEG
abnormalities had been associated with an
increased risk of early death in another study [14],
while infarct size and limb paresis were predictive
of a poor recovery. Two further studies confirmed
the predictive role of atrial fibrillation [39, 43].
Other investigations have had different end-points
yielding different predictive factors. One study
analyzed a heterogeneous group of patients identi-
fying increased age, hemorrhagic stroke, symptom
resolution >72 hours and hyperglycemia, as pre-
dictors of mortality within three months following
disease onset [44]. Another study established that
an eight-day mortality depended only on the level
of consciousness on admission, while death or
dependence during the third month following
stroke depended on the severity of the clinical
deficit, a previous history of stroke and patient age
[45]. Still another examined 300 non-comatose
patients and accurately predicted death or disable-
ment four months following stroke, using age and
the neurological deficit within six hours after dis-
ease onset [46].
Due to the non-comparability of the strata of differ-
ent populations, analyses results that use multiple
regression models are difficult to duplicate [47].
Thus, we decided to investigate our own population.
Despite the inconsistencies mentioned above, we
confirmed the crucial role of simple clinical and
laboratory data which can be used in everyday sit-
uations.
CONCLUSIONS
Our study results, based on a well-defined, consec-
utive and relatively large group of patients with
their first ischemic stroke, indicate that simple clini-
cal data, such as a neurological deficit on admis-
sion or on the next day, decreased consciousness
within 24 hours following stroke onset, or ECG evi-
dence of dysrhythmia, are independent predictors
of a higher 30-day mortality in stroke patients.
These factors should help in considering patient
management guidelines and plan future drug trials.
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